Product Code: VMR112111199
The global demand for High-Resolution Melting Analysis Market is presumed to reach the market size of nearly USD 599.52 MN by 2030 from USD 416.13 MN in 2022 with a CAGR of 4.67% under the study period 2023 - 2030.
High-Resolution Melting Analysis (HRMA) is a molecular biology technique used for detecting and analyzing genetic variations, mutations, and polymorphisms in DNA samples. It is a powerful, rapid, and cost-effective method that can detect single nucleotide polymorphisms (SNPs), insertions, deletions, and other genetic variations in PCR-amplified DNA fragments.
Market Dynamics:
The growing demand for personalized medicine is driving the use of HRMA technology as it enables the detection of genetic variations that can impact individual responses to treatments and disease outcomes. This technology has been widely adopted in genomic research due to its high sensitivity, accuracy, and cost-effectiveness, enabling researchers to analyze genetic variations and identify disease-causing mutations. The increasing prevalence of genetic disorders, such as cancer, cardiovascular diseases, and genetic abnormalities, is driving the demand for HRMA technology as a diagnostic tool for detecting genetic variations and mutations. Technological advancements, such as the development of new fluorescent dyes and advanced PCR machines, have improved the sensitivity and accuracy of this technology, driving its adoption in research and clinical settings. The availability of funding for genomics research from government and private organizations is driving the adoption of HRMA technology for genetic analysis, particularly in the fields of personalized medicine and disease diagnosis. This technology offers a rapid and accurate method for detecting genetic variations, making it an attractive option for diagnostic applications.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of high-resolution melting analysis. The growth and trends of high-resolution melting analysis industry provide a holistic approach to this study.
Market Segmentation:
This section of the high-resolution melting analysis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product & Service
- Instruments
- Reagents And Consumables
- Specialized Pcr Reagents
- Intercalating Dyes
- Software And Services
By Application
- SNP Genotyping
- Mutation Discovery
- Species Identification
- Pathogen Identification
- Epigenetics
- Other
By End User
- Research Laboratories & Academic Institutes
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
- Other
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the High-Resolution Melting Analysis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the high-resolution melting analysis market include Thermo Fisher Scientific Inc. (U.S.), F. Hofmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories (U.S.), and QIAGEN N.V. (Netherlands), Agilent Technologies Inc. (U.S.), bioMerieux S.A. (France), Illumina, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Novacyt (France), Azura Genomics (U.S.), Canon Biomedical (U.S.), and PREMIER Biosoft (U.S.). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . HIGH-RESOLUTION MELTING ANALYSIS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Service
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET ANALYSIS BY PRODUCT & SERVICE
- 5.1 Overview by Product & Service
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Product & Service
- 5.4 Instruments Historic and Forecast Sales by Regions
- 5.5 Reagents And Consumables Historic and Forecast Sales by Regions
- 5.6 Specialized PCR Reagents Historic and Forecast Sales by Regions
- 5.7 Intercalating Dyes Historic and Forecast Sales by Regions
- 5.8 Software And Services Historic and Forecast Sales by Regions
6 . GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET ANALYSIS BY APPLICATION
- 6.1 Overview by Application
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Application
- 6.4 SNP Genotyping Historic and Forecast Sales by Regions
- 6.5 Mutation Discovery Historic and Forecast Sales by Regions
- 6.6 Species Identification Historic and Forecast Sales by Regions
- 6.7 Pathogen Identification Historic and Forecast Sales by Regions
- 6.8 Epigenetics Historic and Forecast Sales by Regions
- 6.9 Other Historic and Forecast Sales by Regions
7 . GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET ANALYSIS BY END USER
- 7.1 Overview by End User
- 7.2 Historical and Forecast Data
- 7.3 Analysis by End User
- 7.4 Research Laboratories & Academic Institutes Historic and Forecast Sales by Regions
- 7.5 Hospitals & Diagnostic Centers Historic and Forecast Sales by Regions
- 7.6 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
- 7.7 Other Historic and Forecast Sales by Regions
8 . GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE HIGH-RESOLUTION MELTING ANALYSIS COMPANIES
- 9.1. High-Resolution Melting Analysis Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF HIGH-RESOLUTION MELTING ANALYSIS INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Thermo Fisher Scientific Inc. (U.S.)
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. F. Hofmann-La Roche Ltd. (Switzerland)
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Bio-Rad Laboratories (U.S.)
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. And QIAGEN N.V. (Netherlands)
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Agilent Technologies Inc. (U.S.)
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. bioMerieux S.A. (France)
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. Illumina Inc. (U.S.)
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Meridian Bioscience Inc. (U.S.)
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. Novacyt (France)
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. Azura Genomics (U.S.)
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
- 10.13. Canon Biomedical (U.S.)
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
- 10.14. PREMIER Biosoft (U.S.)
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies